BS

Baljinder Singh

Active Director Director DIN 10044996
DIN 10044996 First appointment Feb 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2023
Shareholding value •••• Premium profile

About Baljinder Singh

Data last updated:

Baljinder Singh is a Director at Friday Pharma Private Limited (since 2023). Friday Pharma Private Limited reported revenue of ₹38.1 Lakh (FY 2025).

DIN 10044996
Primary Designation Director
First Appointment 10 Feb 2023
Oldest Company Age 3 yrs
Largest company Friday Pharma Private Limited · ₹38.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Friday Pharma Private Limited U46691RJ2023PTC086007
Director10 Feb 20232023₹38.1 Lakh (FY 2025)Active

Board colleagues of Baljinder Singh

NameDINCompanyDesignation
Anil Kumar10044997Friday Pharma Private LimitedDirector
Bheem Singh10044998Friday Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Friday Pharma Private Limited
Premium access

Shareholding and investment profile for Baljinder Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Baljinder Singh

Baljinder Singh currently holds 1 directorship: Friday Pharma Private Limited (Director, since 10 Feb 2023, revenue ₹38.1 Lakh (FY 2025)).

Baljinder Singh was first appointed on 10 Feb 2023 as Director at Friday Pharma Private Limited.

The current boards of Baljinder Singh's companies include Anil Kumar (Friday Pharma Private Limited), Bheem Singh (Friday Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available